Dihydropyrimidinase Deficiency with Severe 5-fluorouracil Toxicity Caused by Capecitabine-Reference-Cited by-同舟云学术

Dihydropyrimidinase Deficiency with Severe 5-fluorouracil Toxicity Caused by Capecitabine

Published:2015 Issue:7 Volume:48 Page:644-649
ISSN:0386-9768
Container-title:The Japanese Journal of Gastroenterological Surgery
language:en
Short-container-title:Jpn J Gastroenterol Surg, Nihon Shokaki Geka Gakkai zasshi

Author:

Yamashita Hiroshi¹,Hiratsuka Masahiro²,Mori Takahiro³,Shigeeda Wataru¹,Kaino Kenji¹,Koyamada Nozomi¹,Akamatsu Yorihiro¹,Abe Keiji¹,Miyazaki Shukichi¹,Kitamura Michihiko¹

Affiliation:

1. Department of Surgery, Iwate Prefectural Chubu Hospital

2. Laboratory of Pharmacotherapy of Life-Style Related Diseases, Graduate School of Pharmaceutical Sciences, Tohoku University

3. Tohoku Community Cancer Service Program, Graduate School of Medicine, Tohoku University

Publisher

The Japanese Journal of Gastroenterological Surgery

Subject

Gastroenterology,Surgery

Link

https://www.jstage.jst.go.jp/article/jjgs/48/7/48_2014.0209/_pdf

Reference29 articles.

1. 1) Perignon JL, Bories DM, Houllier AM, Thuillier L, Cartier PH. Metabolism of pyrimidine bases and nucleosides by pyrimidine-nucleoside phosphorylases in cultured human lymphoid cells. Biochim Biophys Acta. 1987;928(2):130–136.

2. 2) Sumi S, Imaeda M, Kidouchi K, Ohba S, Hamajima N, Kodama K, et al. Population and family studies of dihydropyrimidinuria: prevalence, inheritance mode, and risk of fluorouracil toxicity. Am J Med Genet. 1998;78(4):336–340.

3. 3) Duran M, Rovers P, de Bree PK, Schreuder CH, Beukenhorst H, Dorland L, et al. Dihydropyrimidinuria. Lancet. 1990;336(8718):817–818.

4. 4) Henderson MJ, Ward K, Simmonds HA, Duley JA, Davies PM. Dihydropyrimidinase deficiency presenting in infancy with severe developmental delay. J Inherit Metab Dis. 1993;16(3):574–576.

5. 5) Ohba S, Kidouchi K, Sumi S, Imaeda M, Takeda N, Yoshizumi H, et al. Dihydropyrimidinuria: the first case in Japan. Adv Exp Med Biol. 1994;370:383–386.